Neither oral nor intravenous Vitamin C improve cancer treatment

February 10, 2015

Dr. Mark Clemons recently published a comprehensive review of existing studies to determine whether there is scientifically compelling evidence to support the use of Vitamin C in cancer treatment, either to enhance chemotherapy or reduce its toxicity. The answer is no. Dr. Clemons' team systematically reviewed 34 articles for studies that involved more than 8,000 patients, finding no statistical difference between those who took Vitamin C and those who did not. The paper published in The Oncologist has also been selected for Continuing Medical Education accreditation, an indicator of its medical education impact.

Other authors: Carmel Jacobs, Brian Hutton, Terry Ng and Risa Shorr.

Funders: National Center for Complementary and Alternative Medicine (NCCAM) of the U.S. National Institutes of Health; The Ottawa Hospital Foundation

About the Ottawa Hospital Research Institute
The Ottawa Hospital Research Institute is the research arm of The Ottawa Hospital and is an affiliated institute of the University of Ottawa, closely associated with its faculties of Medicine and Health Sciences. The Ottawa Hospital Research Institute includes more than 1,700 scientists, clinical investigators, graduate students, postdoctoral fellows and staff conducting research to improve the understanding, prevention, diagnosis and treatment of human disease. Support our research. Give to the Tender Loving Research campaign.

Media contact
Paddy Moore
Communications and Public Relations
Ottawa Hospital Research Institute
613-737-8899 x73687
613-323-5680 (cell)